2.19
Therapeuticsmd Inc (TXMD) 最新ニュース
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading.Stock Community Signals - Cổng thông tin điện tử tỉnh Tây Ninh
TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading.Trending Stock Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Form 10-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]: [Amend] - ADVFN
TXMD Should I Buy - Intellectia AI
Total debt per share of TherapeuticsMD, Inc. – MUN:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. stock rises Wednesday, still underperforms market - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
[SCHEDULE 13G] TherapeuticsMD, Inc. Passive Investment Disclosure (>5%) - Stock Titan
Profit Recap: Is TherapeuticsMD Inc stock a buy or sell2026 Review & Real-Time Volume Trigger Notifications - baoquankhu1.vn
TherapeuticsMD Inc. (TXMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
TherapeuticsMD Inc. R (29TA.F) stock price, news, quote and history - Yahoo Finance UK
TherapeuticsMD Explains Brief Delay In Annual Filing - The Globe and Mail
TherapeuticsMD 2025 Annual Report: Business Overview, Risk Factors, and Intellectual Property Challenges - Minichart
[10-K/A] TherapeuticsMD, Inc. Amends Annual Report - Stock Titan
TherapeuticsMD Inc. stock rises Tuesday, still underperforms market - MarketWatch
TherapeuticsMD, Inc. (TXMD) stock price, news, quote and history - Yahoo Finance UK
TherapeuticsMD Announces Full Year 2025 Financial Results - BioSpace
TherapeuticsMD (NASDAQ: TXMD) files 2025 Form 10-K after printer error - Stock Titan
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy - TipRanks
TXMD Reports $7.5 Million in Cash Holdings as of Year-End 2025 - GuruFocus
TXMD: Net loss narrowed and license revenue surged as strategic alternatives are explored - TradingView
TXMD: 2025 saw improved results from royalty revenue, but litigation and liquidity risks threaten viability - TradingView — Track All Markets
TherapeuticsMD (NASDAQ: TXMD) reports 2025 results, weighs strategic options - Stock Titan
[10-K] TherapeuticsMD, Inc. Files Annual Report - Stock Titan
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TXMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
TherapeuticsMD, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Lumentum Holdings Leads Six-Month Stock Performance with 425.03% Return - Markets Mojo
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
Insider Trends: Whats next for TherapeuticsMD Inc stockQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Market Overview: Whats next for TherapeuticsMD Inc stockEarnings Growth Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
Lumentum Holdings Leads Stock Performance with 311.87% Return in Six Months - Markets Mojo
If You Invested $1,000 in Therapeuticsmd Inc (TXMD) - Stock Titan
Investment Report: Is TherapeuticsMD Inc forming a double bottom2026 Winners & Losers & High Conviction Buy Zone Alerts - baoquankhu1.vn
Breakout Move: Is TherapeuticsMD Inc stock a falling knife or bargain buy2025 Analyst Calls & Smart Investment Allocation Tips - baoquankhu1.vn
TXMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volatility Watch: Is TherapeuticsMD Inc stock heavily shortedJuly 2025 Intraday Action & Stepwise Swing Trade Plans - baoquankhu1.vn
TXMD PE Ratio & Valuation, Is TXMD Overvalued - Intellectia AI
Should I hold or sell BTC Digital Ltd nowEarnings Overview Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Is TherapeuticsMD Inc. forming a double bottom2025 Key Lessons & Weekly Momentum Picks - mfd.ru
What are analysts’ price targets for TherapeuticsMD Inc.Market Trend Report & Fast Exit and Entry Strategy Plans - mfd.ru
Is TherapeuticsMD Inc. stock a buy or sell2025 Retail Activity & Daily Profit Maximizing Trade Tips - mfd.ru
大文字化:
|
ボリューム (24 時間):